Trajan Wealth LLC Invests $19.35 Million in The Cooper Companies, Inc. $COO

Trajan Wealth LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 269,803 shares of the medical device company’s stock, valued at approximately $19,348,000. Trajan Wealth LLC owned 0.14% of Cooper Companies as of its most recent SEC filing.

Several other large investors have also bought and sold shares of COO. New York Life Investment Management LLC grew its holdings in Cooper Companies by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares during the period. Root Financial Partners LLC raised its position in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares in the last quarter. Essential Partners LLC lifted its holdings in Cooper Companies by 23.4% in the 1st quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after acquiring an additional 166 shares during the last quarter. Allworth Financial LP lifted its holdings in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares during the last quarter. Finally, SJS Investment Consulting Inc. boosted its position in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 0.6%

NASDAQ:COO opened at $75.80 on Tuesday. The stock’s 50-day moving average is $72.09 and its two-hundred day moving average is $71.07. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The stock has a market cap of $14.78 billion, a PE ratio of 64.24, a price-to-earnings-growth ratio of 1.99 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the firm earned $0.96 EPS. The company’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Citigroup restated a “neutral” rating and set a $80.00 target price (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Stifel Nicolaus decreased their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Needham & Company LLC cut their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Finally, Wells Fargo & Company restated a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.